Gingerol is an analgesic, hypoglycemic, hepatoprotective, immune-stimulant, anti-inflammatory agents. In traditional medicine, gingerol has been proven plenty of pharmacological properties such as bactericidal, microbicidal, potent antioxidant, antifertility, tuberculostatic and anticancer. The key objective of this work was to develop, validate and estimate gingerol by RP-HPLC method. According to the ICH guidelines, a stabilityindicating RP-HPLC method was developed and validated. In this method, reverse phase enable Cosmosil C18 column (250 × 4.6 mm, 5μm) was used in isocratic mode. The mobile phase consisted of acetonitrile: methanol: water (52: 8: 40 v/v) delivered at a flow rate of 1.0 mL min -1 . The elute injection volume was 20 µL that was analyzed by a UV detector at 280 nm. Linearity range of the concentration of gingerol was 20 μg mL -1 -140 μg mL -1 and the correlation coefficient R 2 value was found to be 0.997 ± 0.11. Recovery was found to be in the range of 98.16 -100.07 %. The limit of detection (LOD) of gingerol was found to be 2.23 μg mL -1 and limit of quantitation (LOQ) was 5.02 μg mL -1 . Gingerol was subjected to stress conditions including acidic, alkaline, neutral, oxidation, and dry heat degradation. Gingerol was more sensitive to alkaline, dry heat and oxidative degradation and it is stable at acidic conditions. The method was validated according to ICH guidelines.